February 27, 2015 News by Patricia Silva, PhD Translational Medicine Consortium Grants $1.9 Million for MS Research The Strategic Pharma-Academic Research Consortium for Translational Medicine has awarded its first grants totaling more than $1.9 million to support research projects dedicated to autoimmune diseases. Among the recipients is researcher Yanjiao Zhou, Ph.D., who is leading a study at Washington University in St. Louis (WUSTL) focused on multiple sclerosis (MS), as…
February 26, 2015 News by admin EXCLUSIVE: Multiple Sclerosis, Falls and Home Exercise to be Studied at University of Illinois, Urbana Champaign Dr. Jacob Sosnoff wants to know more about falling — something that few multiple sclerosis (MS) researchers focus on, even though it is a daily threat for many people with the disease. Sosnoff, an Associate Professor in the Department of Kinesiology and Community Health at the …
February 25, 2015 News by Patricia Inacio, PhD Likelihood of MS, Other Autoimmune Disorders in Women Increased By Mercury in Seafood According to Study A new study entitled “Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the United States” suggests mercury exposure by seafood may increase the risk of developing autoimmune diseases in women. The study was published in the journal Environmental Health Perspectives. Autoimmune disorders…
February 24, 2015 News by Isaura Santos Pathological Progression of Multiple Sclerosis Documented For The First Time An international group of researchers from the Center for Brain Research at the MedUni Vienna have published a paper in the Lancet Neurology journal titled “Pathological mechanisms in progressive multiple sclerosis,” documenting the pathological progress of MS since its early stages to what is known about…
February 23, 2015 News by Patricia Silva, PhD Spinal Cord Alteration in Multiple Sclerosis Could Lead to New Therapeutic Target A recent study led by researchers at the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada revealed a promising new method for multiple sclerosis (MS) treatment. The study was published in the journal Annals of Clinical and Translational Neurology and is…
February 20, 2015 News by Kara Elam Study on Immune Response in MS, Other Autoimmune Diseases Targets New Therapeutic Approach A study published by a team of investigators at the University of Tokyo’s Institute of Medical Science and Osaka University’s Graduate School of Engineering presented new evidence demonstrating how Toll-like receptor 9 (TLR9) binds to pathogenic DNA, turning on the functions of the innate immune…
February 19, 2015 News by Patricia Silva, PhD National MS Society Now Sponsored by Key Bike MS Supporter The National Multiple Sclerosis Society will receive an annual sponsorship from Showers Pass to support its efforts to improve the quality of life of patients suffering from multiple sclerosis (MS) as well as to find a cure for the disease. Showers Pass manufactures biking clothes and material and supports the…
February 18, 2015 News by admin Multiple Sclerosis Study Explores Walking, Cycling, Yoga Effects on Cognition A new study suggests that different types of physical activity might help the mental processes of people with multiple sclerosis. The research comes from the University of Illinois and the State University of New York at Buffalo, and appeared in the February 6th issue of the…
February 17, 2015 News by admin Multiple Sclerosis: How Can MRI Measurements be Improved in Trials? A study from German researchers might help to determine how multiple sclerosis is assessed in treatment trials. Published February 6 in the journal PLoS ONE, the study is titled “Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts –…
February 16, 2015 News by Maureen Newman Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial What may work better than existing drugs to treat severe multiple sclerosis? Stem cells. A phase 2 clinical study from an international group of research centers compared head-to-head autologous hematopoietic stem cell transplantation (AHSCT) and mitoxantrone in treating patients with secondary progressive or relapsing-remitting multiple sclerosis. The findings showed that…
February 13, 2015 News by Maureen Newman Experimental SPMS Drug From Innate Immunotherapeutics Shows Success in Early Trials Under development at Innate Immunotherapeutics is a special drug candidate to treat secondary progressive multiple sclerosis (SPMS). Currently, no viable therapies exist for SPMS — only less-effective means to treat SPMS patients through drugs designed for relapse-remitting multiple sclerosis — making the prospect of Innate’s experimental SPMS therapy a…
February 12, 2015 News by Patricia Silva, PhD Accelerated Cure Project to Increase Participation in MS Trials Nonprofit organization, Accelerated Cure Project for Multiple Sclerosis, is launching a national campaign called iConquerMS, which was designed by and for multiple sclerosis patients to raise awareness of the importance of health data and supporting research. On the iConquerMS portal, patients can…
February 11, 2015 News by Patricia Silva, PhD Scientists Update Recommendations on MS Research Several renowned scientists working on multiple sclerosis (MS) recently joined forces to discuss and highlight the progress and knowledge gaps related to MS research, the prospects of finding a cure for the disease, and a strategy to reduce the burden the disease places on patients. A series of articles was published by the researchers in the…
February 10, 2015 News by Patricia Silva, PhD Creative Medical Seeks Patent for Stem Cell Therapy for MS Phoenix, Arizona-based Creative Medical Health (CMH) has just announced it has submitted a patent application for its proprietary mesenchymal stem cell pipeline product, indicated for autoimmune diseases. The company is already preparing to launch the product into its first line of clinical tests, which will…
February 9, 2015 News by Charles Moore Leading Developer Of Cannabis-Based Therapeutics Nemus To Address MS, Other Unmet Medical Needs The 2012 and 2014 ballots approving legalization of cannabis in four U.S. states have stirred the pot, so to speak, on a wide range of issues and nuances related to the herb — not least marijuana’s clinical use as a therapeutic agent. Medical marijuana remains a topic of debate…
February 6, 2015 News by admin Acorda Announces Phase 1 Results for Remyelinating Antibody in Multiple Sclerosis Acorda Therapeutics, Inc. has released results from a Phase 1 clinical trial of rHIgM22 for multiple sclerosis, showing that the medication is safe and produces few side effects. rHIgM22 is a medication that may induce the re-wrapping of the myelin sheath that surround nerve cells,…
February 5, 2015 News by Patricia Silva, PhD Novel Antibody Drug Candidate From Chinese Drug Developer Shows Promise For Treating MS MicroConstants China, Inc., a company that provides preclinical, clinical, and consulting services to biotechnology and pharmaceutical companies, has just announced it has acquired international rights to the development of AA98 antibody pipeline products, indicated for the treatment of several types of cancer, multiple sclerosis, and age related macular degeneration…
February 4, 2015 News by admin MediciNova To Present on Multiple Sclerosis Therapy at American Academy of Neurology 67th Annual Meeting MediciNova, Inc., has announced the acceptance of an abstract describing their ongoing Phase 2b clinical trial of MN-166 (ibudilast) in progressive multiple sclerosis (MS). The poster is to be presented at the American Academy of Neurology (AAN) 67th Annual Meeting, April 18 – 25, 2015 in Washington, DC. The presentation is titled…
February 3, 2015 News by Patricia Silva, PhD Phase I Clinical Studies To Begin Using Anatabine Citrate as Possible Therapy For MS Drug development company Rock Creek Pharmaceuticals, Inc. recently announced that a new clinical trial application with the United Kingdom’s Medicines Healthcare Products Regulatory Agency (MHRA) has been approved. The company is set to proceed with a Phase I study of its flagship pipeline product, Anatabine Citrate, a chemical that is found naturally…
February 2, 2015 News by Patricia Silva, PhD Helicobacter Pylori Infection May Help Protect Against Multiple Sclerosis in Females A new study on the association between Helicobacter pylori and multiple sclerosis (MS) entitled “Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females” was published in the Journal of Neurology, Neurosurgery & Psychiatry by Marzena J. Fabis Pedrini from the Centre…
